stockrow
Friday 6 November 2026
Export STDN’s income statement to Excel — free account
Standard Nuclear Inc
STDN Basic Materials Specialty Chemicals
Standard Nuclear Inc’s revenue for fiscal 2025 (year ended December 2025) was $3.1 million.
11.82
0.32
+2.78%
Follow STDN
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Jun ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | — | — | 3 | — | — | 17 | 61 | 326 | +369.8% | |
| Gross margin, % | — | — | — | — | — | — | — | — | — | 100.00 | — | — | ||||||
| EBT | — | — | — | — | — | — | — | — | — | 3 | — | — | ||||||
| EBT margin, % | — | — | — | — | — | — | — | — | — | 100.00 | — | — | ||||||
| Net income | — | — | — | — | — | — | — | — | — | — | — | — | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | — | — | — | 0.11 | 0.00 | — | |||||
| Earnings | — | — | — | — | — | — | — | — | — | (0.55) | — | — | ||||||
| Cash flow | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | — | ||||||
| Capex | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | — | ||||||
| Free cash flow | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | — | ||||||
| Book value | — | — | — | — | — | — | — | — | — | 0.00 | (2.77) | — | ||||||
| Shares, m | — | — | — | — | — | — | — | — | — | 28 | — | — | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | — | — | |||||
| P/S | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | — | ||||||
| P/B | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | — | ||||||
| EV/Sales | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | — | ||||||
| EV/FCF | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | — | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | — | — | — | — | — | |||||
| Capex | — | — | — | — | — | — | — | — | — | — | — | — | ||||||
| Free cash flow | — | — | — | — | — | — | — | — | — | — | — | — | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | — | — | — | — | 104 | — | |||||
| Net debt | — | — | — | — | — | — | — | — | — | — | (102) | — | ||||||
| Shareholders’ equity | — | — | — | — | — | — | — | — | — | — | (78) | — | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | — | — | — | 0.00 | — | — | |||||
| ROIC | — | — | — | — | — | — | — | — | — | 0.00 | 0.00 | — | ||||||
| ROE | — | — | — | — | — | — | — | — | — | 0.00 | — | — | ||||||
| People | ||||||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | — | — | — | — | |||||
| Revenue/emp, $m | — | — | — | — | — | — | — | — | — | 0.00 | — | — | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Jun 2026 · fundamentals updated 2 Nov 2026
Standard Nuclear Inc vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| WDFC WD-40 Company | $3.0B | 37.0× | 32.3× | +8.14% (above 0%: growing) | −31.85% (below 0%: shrinking) | +63.49% (above 0%: growing) | 52.78% | 10.78% | Compare |
| FUL H. B. Fuller Company | $2.7B | 13.8× | 11.7× | +5.17% (above 0%: growing) | +18.19% (above 0%: growing) | −58.41% (below 0%: shrinking) | 33.22% | 12.07% | Compare |
| KWR Quaker Houghton | $2.6B | 27.2× | 21.6× | +10.27% (above 0%: growing) | −0.42% (below 0%: shrinking) | −92.40% (below 0%: shrinking) | 35.54% | 8.97% | Compare |
| NGVT Ingevity Corporation | $2.2B | 42.0× | 18.4× | −5.25% (below 0%: shrinking) | n/m | −136.08% (below 0%: shrinking) | 44.25% | 19.13% | Compare |
| IOSP Innospec Inc. | $2.0B | 13.9× | 19.5× | +7.17% (above 0%: growing) | +146.71% (above 0%: growing) | −88.68% (below 0%: shrinking) | 27.26% | 8.80% | Compare |
| MTX Minerals Technologies Inc. | $1.9B | — (loss-making) | — (loss-making) | +4.23% (above 0%: growing) | +2.80% (above 0%: growing) | +19.04% (above 0%: growing) | 23.28% | 11.68% | Compare |
| CC The Chemours Company | $1.9B | — (loss-making) | — (loss-making) | +3.01% (above 0%: growing) | +223.80% (above 0%: growing) | −12.50% (below 0%: shrinking) | 15.00% | 14.87% | Compare |
| STDN Standard Nuclear Inc | $1.8B | — | — | — | n/m | — | 67.21% | (90.70%) | |
| SCL Stepan Company | $1.5B | 361× | — (loss-making) | +17.26% (above 0%: growing) | +65.47% (above 0%: growing) | −4.42% (below 0%: shrinking) | 12.65% | 3.75% | Compare |
| Median of peers | $2.1B | 32.1× | 19.5× | +6.17% | +18.19% | −35.45% | 30.24% | 11.23% |